Trade VKTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Viking Therapeutics, Inc. (VKTX) is trading at US$28.99, down 1.26% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$3.95B. Over the past 52 weeks, VKTX has traded between US$24.52 and US$43.15. On Syfe you can trade VKTX with $0 commission and add it to your watchlist.
| Previous close | US$29.36 |
|---|---|
| Market cap | US$3.95B |
| 52-week range | US$24.52 – US$43.15 |
| Volume | 2.67M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Year: 2015
Viking Therapeutics' VK2735 Drives Substantial Optionality, Oppenheimer Says
Aug 3, 4:44 PM · MT Newswires
Viking's Obesity Treatments Advance as New Data, Trials Loom, Oppenheimer Says
Jul 30, 6:17 PM · MT Newswires
Viking Therapeutics' Q2 Net Loss Widens
Jul 30, 8:23 AM · MT Newswires
Viking Therapeutics Insider Sold Shares Worth $609,636, According to a Recent SEC Filing
Jul 30, 8:15 AM · MT Newswires
Viking Therapeutics Insider Sold Shares Worth $710,141, According to a Recent SEC Filing
Jul 30, 8:15 AM · MT Newswires
Viking Therapeutics, Inc. (VKTX) stock is trading at US$28.99, -1.26% from the previous close of US$29.36.
The market cap for Viking Therapeutics, Inc. (VKTX) stock is approximately US$3.95B.
The 52-week high for Viking Therapeutics, Inc. (VKTX) stock is US$43.15.
The 52-week low for Viking Therapeutics, Inc. (VKTX) stock is US$24.52.
Viking Therapeutics, Inc. (VKTX) does not currently pay a dividend.
Stay on top of VKTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
